WO1998031348A1 - Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung - Google Patents
Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung Download PDFInfo
- Publication number
- WO1998031348A1 WO1998031348A1 PCT/EP1998/000013 EP9800013W WO9831348A1 WO 1998031348 A1 WO1998031348 A1 WO 1998031348A1 EP 9800013 W EP9800013 W EP 9800013W WO 9831348 A1 WO9831348 A1 WO 9831348A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- limonene
- acetylsalicylic acid
- therapeutic system
- dimethyl isosorbide
- transdermal therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002277366A CA2277366A1 (en) | 1997-01-15 | 1998-01-03 | Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption |
EP98902976A EP1023053A1 (de) | 1997-01-15 | 1998-01-03 | Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung |
JP53137698A JP2001508069A (ja) | 1997-01-15 | 1998-01-03 | 吸収性を高めたアセチルサリチル酸含有経皮吸収治療システム |
AU59862/98A AU726094B2 (en) | 1997-01-15 | 1998-01-03 | Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement |
NO993435A NO993435L (no) | 1997-01-15 | 1999-07-12 | Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19701059.8 | 1997-01-15 | ||
DE19701059A DE19701059C2 (de) | 1997-01-15 | 1997-01-15 | Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998031348A1 true WO1998031348A1 (de) | 1998-07-23 |
Family
ID=7817375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/000013 WO1998031348A1 (de) | 1997-01-15 | 1998-01-03 | Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1023053A1 (de) |
JP (1) | JP2001508069A (de) |
KR (1) | KR20000070228A (de) |
AU (1) | AU726094B2 (de) |
CA (1) | CA2277366A1 (de) |
DE (1) | DE19701059C2 (de) |
NO (1) | NO993435L (de) |
WO (1) | WO1998031348A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003511408A (ja) * | 1999-10-13 | 2003-03-25 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセチルサリチル酸および/またはサリチル酸投与用の経皮治療システム |
US8936813B2 (en) | 2001-11-01 | 2015-01-20 | Novartis Ag | Spray drying methods and related compositions |
IT202000014578A1 (it) * | 2020-06-18 | 2021-12-18 | Poli Md S R L | Dispositivo medicale comprendente acido acetil salicilico |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19949252B4 (de) * | 1999-10-13 | 2004-02-12 | Lts Lohmann Therapie-Systeme Ag | Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung |
DE19959913A1 (de) * | 1999-12-11 | 2001-06-28 | Lohmann Therapie Syst Lts | Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne |
KR100448469B1 (ko) * | 2001-10-26 | 2004-09-13 | 신풍제약주식회사 | 항염증제의 경피 조성물 및 장치 |
DE10338162B3 (de) † | 2003-08-20 | 2005-06-02 | Haldex Brake Products Gmbh | Verfahren zum Betreiben einer Druckluftbeschaffungsanlage eines Kraftfahrzeuges sowie Druckluftaufbereitungseinrichtung |
DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
DE102005050431A1 (de) * | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228162A (en) * | 1979-07-09 | 1980-10-14 | Research Corporation | Dimethyl isosorbide in liquid formulation of aspirin |
US5164416A (en) * | 1989-02-03 | 1992-11-17 | Lintec Corporation | Transdermal therapeutic formulation containing a limonene |
DE4332094A1 (de) * | 1993-09-22 | 1995-03-23 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4332093C2 (de) * | 1993-09-22 | 1995-07-13 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung |
-
1997
- 1997-01-15 DE DE19701059A patent/DE19701059C2/de not_active Expired - Fee Related
-
1998
- 1998-01-03 AU AU59862/98A patent/AU726094B2/en not_active Ceased
- 1998-01-03 WO PCT/EP1998/000013 patent/WO1998031348A1/de not_active Application Discontinuation
- 1998-01-03 JP JP53137698A patent/JP2001508069A/ja active Pending
- 1998-01-03 EP EP98902976A patent/EP1023053A1/de not_active Withdrawn
- 1998-01-03 KR KR1019997006454A patent/KR20000070228A/ko not_active Application Discontinuation
- 1998-01-03 CA CA002277366A patent/CA2277366A1/en not_active Abandoned
-
1999
- 1999-07-12 NO NO993435A patent/NO993435L/no not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4228162A (en) * | 1979-07-09 | 1980-10-14 | Research Corporation | Dimethyl isosorbide in liquid formulation of aspirin |
US5164416A (en) * | 1989-02-03 | 1992-11-17 | Lintec Corporation | Transdermal therapeutic formulation containing a limonene |
DE4332094A1 (de) * | 1993-09-22 | 1995-03-23 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003511408A (ja) * | 1999-10-13 | 2003-03-25 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセチルサリチル酸および/またはサリチル酸投与用の経皮治療システム |
JP4938949B2 (ja) * | 1999-10-13 | 2012-05-23 | エルテーエス ローマン テラピー−ジステーメ アーゲー | アセチルサリチル酸および/またはサリチル酸投与用の経皮治療システム |
US8936813B2 (en) | 2001-11-01 | 2015-01-20 | Novartis Ag | Spray drying methods and related compositions |
IT202000014578A1 (it) * | 2020-06-18 | 2021-12-18 | Poli Md S R L | Dispositivo medicale comprendente acido acetil salicilico |
Also Published As
Publication number | Publication date |
---|---|
CA2277366A1 (en) | 1998-07-23 |
AU726094B2 (en) | 2000-11-02 |
NO993435D0 (no) | 1999-07-12 |
DE19701059A1 (de) | 1998-07-16 |
DE19701059C2 (de) | 2000-12-21 |
NO993435L (no) | 1999-07-12 |
AU5986298A (en) | 1998-08-07 |
JP2001508069A (ja) | 2001-06-19 |
KR20000070228A (ko) | 2000-11-25 |
EP1023053A1 (de) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0617972B1 (de) | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)-acrylat-Mischung | |
EP0430019B1 (de) | Transdermales therapeutisches System mit Buprenorphin als aktivem Bestandteil | |
EP0665745B1 (de) | Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung | |
DE19922662C1 (de) | Transdermales therapeutisches System (TTS) Tolterodin enthaltend | |
EP0720474B1 (de) | Lösemittelfrei herstellbares wirkstoffpflaster enthaltend flüchtige inhaltsstoffe | |
DE19548332A1 (de) | Hormonpflaster | |
WO1994016707A1 (de) | Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil | |
WO1996029999A1 (de) | Transdermal applizierbares arzneimittel mit ace-hemmern | |
WO1999059558A1 (de) | Transdermales therapeutisches system (tts) pergolid enthaltend | |
EP1003477B1 (de) | Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel | |
EP2265264A1 (de) | Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff hiervon | |
EP0305726B1 (de) | Transdermales therapeutisches System | |
EP0122574A1 (de) | Teilbare Tablette mit verzögerter Wirkstofffreigabe und Verfahren zu deren Herstellung | |
DE19906152A1 (de) | Wirkstoffhaltige Laminate für Transdermalsysteme | |
EP0709088B1 (de) | Transdermales therapeutisches System zur Applikation von Naloxon | |
EP0721334B1 (de) | Transdermales therapeutisches system enthaltend octyldodecanol als kristallisationsinhibitor | |
WO1998031348A1 (de) | Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung | |
WO1996008251A1 (de) | Scopolaminpflaster | |
EP0319555B1 (de) | Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung | |
WO1992020378A1 (de) | Lanolinderivate als penetrationsfördernde substanzen | |
EP0776199B1 (de) | Estradiol-tts mit wasserbindenden zusätzen | |
EP0880366B1 (de) | Hauthaftende pharmazeutische zubereitung, insbesondere tts zur abgabe von 17-beta-estradiol an den menschlichen organismus | |
DE10025971A1 (de) | Transdermales therapeutisches System mit verminderter Tendenz zur Wirkstoffkristallisation | |
DE4438989A1 (de) | Scopolaminpflaster | |
WO2020182378A1 (de) | Phenprocoumon-tts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR MX NO SI US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998902976 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2277366 Country of ref document: CA Ref country code: JP Ref document number: 1998 531376 Kind code of ref document: A Format of ref document f/p: F Ref country code: CA Ref document number: 2277366 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/006584 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997006454 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 59862/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09341493 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998902976 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997006454 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 59862/98 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998902976 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997006454 Country of ref document: KR |